Navarra, Pierluigi
 Distribuzione geografica
Continente #
EU - Europa 7.222
NA - Nord America 5.971
AS - Asia 2.068
SA - Sud America 253
AF - Africa 22
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.556
Nazione #
US - Stati Uniti d'America 5.900
DE - Germania 2.402
PL - Polonia 1.113
IT - Italia 1.074
SE - Svezia 858
SG - Singapore 803
CN - Cina 764
UA - Ucraina 475
FR - Francia 342
GB - Regno Unito 250
IE - Irlanda 247
BR - Brasile 217
ID - Indonesia 154
IN - India 150
FI - Finlandia 146
RU - Federazione Russa 106
TR - Turchia 60
NL - Olanda 50
BE - Belgio 45
CA - Canada 40
HK - Hong Kong 24
MX - Messico 23
JP - Giappone 19
ES - Italia 18
IR - Iran 17
VN - Vietnam 17
CH - Svizzera 16
CZ - Repubblica Ceca 16
AU - Australia 14
AT - Austria 13
CL - Cile 12
GR - Grecia 8
IL - Israele 7
MA - Marocco 7
KR - Corea 6
LT - Lituania 6
RO - Romania 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
EC - Ecuador 5
LV - Lettonia 5
AR - Argentina 4
HU - Ungheria 4
IQ - Iraq 4
NO - Norvegia 4
PE - Perù 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BD - Bangladesh 3
BO - Bolivia 3
CO - Colombia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KE - Kenya 3
SA - Arabia Saudita 3
TH - Thailandia 3
UZ - Uzbekistan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
EG - Egitto 2
EU - Europa 2
KZ - Kazakistan 2
MN - Mongolia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 15.556
Città #
Chandler 1.197
Warsaw 1.019
Ashburn 513
Singapore 414
Jacksonville 317
San Mateo 274
Dublin 247
Fairfield 228
Verona 227
Wilmington 223
Nanjing 201
Houston 187
Ann Arbor 181
Woodbridge 157
New York 150
Jakarta 149
Milan 148
Nürnberg 144
Cattolica 142
Seattle 134
Bremen 127
Rome 112
Dearborn 110
Munich 99
Kraków 88
Cambridge 87
Lawrence 85
Boston 82
Moscow 80
Nanchang 80
Marseille 76
Redwood City 63
Chicago 56
Beijing 55
Princeton 55
Izmir 47
Los Angeles 46
Brussels 45
Mountain View 43
The Dalles 43
Helsinki 40
Lancaster 38
Kunming 36
Hangzhou 35
Boardman 33
Shenyang 33
North Bergen 32
University Park 32
Jiaxing 30
Leawood 29
Düsseldorf 27
Fremont 27
Tianjin 25
Changsha 23
Hebei 23
Pune 23
Hong Kong 22
Nuremberg 22
Frankfurt am Main 21
Guangzhou 21
Hyderabad 21
Redmond 21
Shanghai 21
Philadelphia 20
Falkenstein 19
London 19
Norwalk 18
San Diego 18
Zhengzhou 18
Lauterbourg 16
Toronto 16
Dong Ket 14
Naples 14
Ottawa 14
São Paulo 14
Phoenix 13
Brasília 12
Busto Arsizio 12
Jinan 12
Nutley 12
Augusta 11
Paris 11
Falls Church 10
Scottsdale 10
Washington 10
Costa Mesa 9
Detroit 9
Lappeenranta 9
Monmouth Junction 9
Montesilvano Marina 9
Portsmouth 9
Salvador 9
Simi Valley 9
Andover 8
Ferrara 8
Sydney 8
Athens 7
Brno 7
Hefei 7
Indiana 7
Totale 8.803
Nome #
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 365
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 356
mTOR kinase: a possible pharmacological target in the management of chronic pain 355
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 326
Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of BCL-XL gene expression. 316
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 314
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 312
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 308
The human microglial HMC3 cell line: where do we stand? A systematic literature review 281
The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 269
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 233
The role of small intestinal bacterial overgrowth in Parkinson's disease 191
Full HTA di Emicizumab 187
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 184
Effects of remifentanil on human C20 microglial pro-inflammatory activation 180
Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells 178
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 167
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 161
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 153
Produzione in vitro e in vivo di interleuchina-1 dopo una convulsione febbrile 147
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 145
Antiretrovirals inhibit arginase in human microglia 139
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 139
Variability of raltegravir plasma levels in the clinical setting 136
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 134
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 132
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature 129
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 128
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 125
Utilizzo degli antidepressivi e caratteristiche socio-economiche nelle regioni italiane. Evidenze da uno studio ecologico. 124
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 122
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 122
N-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. 121
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 120
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. 119
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 119
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 119
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 118
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 117
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 116
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 116
Pro-inflammatory activation of a new immortalized human microglia cell line 115
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 114
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 113
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 112
Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat 112
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 111
The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis 110
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 109
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. 108
Antiretrovirals inhibit arginase in human microglia 108
AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. 107
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 105
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 105
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 104
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 101
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 99
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 98
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 98
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 98
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 97
Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay 97
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. 96
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 96
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 96
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 95
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 94
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 93
A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 92
Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization 92
beta-Carotene Downregulates the Steady-State and Heregulin-{alpha}-Induced COX-2 Pathways in Colon Cancer Cells. 91
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients 91
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 90
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 90
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 89
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 85
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 85
Molecular and pharmacological evidence for a facilitatory functional role of presynaptic GLUK2/3 kainate receptors on GABA release in rat trigeminal caudal nucleus. 85
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 85
Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol. 84
Exploiting microglial functions for the treatment of glioblastoma 84
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 83
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 83
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 83
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 81
Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy 80
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 80
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 79
P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals 79
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 78
Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. 78
Pharmacokinetic profile of Oncofid-S after intraperitoneal and intravenous administration in the rat. 78
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 77
Exploiting Microglial Functions for the Treatment of Glioblastoma 76
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 76
Interactions between Integrase Inhibitors and human Arginase 1 75
Death to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 74
Relationship between blood remifentanil concentration and stress hormone levels during pneumoperitoneum in patients undergoing laparoscopic cholecystectomy 73
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. 72
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 71
Totale 13.033
Categoria #
all - tutte 61.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020386 0 0 0 0 0 0 0 0 0 0 243 143
2020/20211.436 77 157 24 151 171 74 216 34 188 99 204 41
2021/20221.711 149 112 26 102 120 64 42 235 72 96 429 264
2022/20233.106 356 452 241 520 243 367 115 271 345 48 93 55
2023/20241.630 89 396 66 153 82 219 118 54 30 57 182 184
2024/20252.055 77 87 224 120 260 134 59 178 544 300 72 0
Totale 15.760